Advanced search
Publication Cover
Acta Cardiologica Volume 77, 2022 - Issue 3
Submit an article Journal homepage
113
Views
8
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Assessment of COVID-19 deaths from cardiological perspective

Timor Omara Department of Cardiology, M.D. Kars Harakani State Hospital, Kars, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2481-0505
ORCID Icon,
Muammer Karakayalıa Department of Cardiology, M.D. Kars Harakani State Hospital, Kars, TurkeyORCID Iconhttps://orcid.org/0000-0001-7385-120X
ORCID Icon &
Gökhan Perincekb Department of Chest Diseases, M.D. Kars Harakani State Hospital, Kars, TurkeyORCID Iconhttps://orcid.org/0000-0003-2400-6346
ORCID Icon
Pages 231-238 | Received 21 Jan 2021, Accepted 10 Mar 2021, Published online: 07 Apr 2021

References

  • WHO. WHO Coronavirus Disease (COVID-19) Dashboard. Available from: https://covid19.who.int
  • Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–818.
  • Smilowitz NR, Jethani N, Chen J, et al. Myocardial injury in adults hospitalized with COVID-19. Circulation. 2020;142(24):2393–2395.
  • Bertini M, Ferrari R, Guardigli G, et al. Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement. Europace. 2020;22(12):1848–1854.
  • Surawicz BKTC. Chou’s electrocardiography in clinical practice. 6th ed. Philadelphia (PA): Saunders; 2008.
  • Anon. 2020. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance
  • Roca E, Lombardi C, Campana M, et al. Takotsubo syndrome associated with COVID-19. Eur J Case Rep Intern Med. 2020;7(5):1.
  • Farré N, Mojón D, Llagostera M, et al. Prolonged QT interval in SARS-CoV-2 infection: prevalence and prognosis. JCM. 2020;9(9):2712.
  • Ghio S, Baldi E, Vicentini A, San Matteo COVID Cardiac Injury Task Force. Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy. Intern Emerg Med. 2020;15(8):1457–1465.
  • Maeda T, Obata R, Rizk D, et al. Cardiac Injury and Outcomes of Patients with COVID-19 in New York City. Heart Lung Circ. 2020.
  • Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm . 2020;17(9):1463–1471.
  • Paul JF, Charles P, Richaud C, et al. Myocarditis revealing COVID-19 infection in a young patient. Eur Heart J Cardiovasc Imaging. 2020;21(7):776–776.
  • Kim I-C, Song JE, Lee HJ, et al. The implication of cardiac injury score on in-hospital mortality of coronavirus disease 2019. J Korean Med Sci. 2020;35:e349.
  • Salvatici M, Barbieri B, Cioffi SMG, et al. Association between cardiac troponin I and mortality in patients with COVID-19. Biomarkers. 2020;25(8):634–640.
  • Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819–824.
  • Dabbagh MF, Aurora L, D'Souza P, et al. Cardiac tamponade secondary to COVID-19. JACC Case Rep. 2020;2(9):1326–1330.
  • Vidovich MI. Transient Brugada-like electrocardiographic pattern in a patient with COVID-19. JACC Case Rep. 2020;2(9):1245–1249.
  • Asif T, Ali Z. Transient ST segment elevation in two patients with COVID-19 and a normal transthoracic echocardiogram. Eur J Case Rep Intern Med. 2020;7:001672.
  • Gopinathannair R, Merchant FM, Lakkireddy DR, et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol. 2020;59(2):329–336.
  • Giustino G, Croft LB, Stefanini GG, et al. Characterization of myocardial injury in patients with COVID-19. J Am Coll Cardiol. 2020;76(18):2043–2055.
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395(10223):497–506.
  • Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan. JAMA Cardiol. 2020;5(7):802.
  • Kuno T, Takahashi M, Obata R, et al. Cardiovascular comorbidities, cardiac injury, and prognosis of COVID-19 in New York City. Am Heart J. 2020;226:24–25.
  • Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481.
  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
  • De Vita A, Ravenna SE, Covino M, et al. Electrocardiographic findings and clinical outcome in patients with COVID-19 or other acute infectious respiratory diseases. JCM. 2020;9(11):3647.
  • Long B, Brady WJ, Bridwell RE, et al. Electrocardiographic manifestations of COVID-19. Am J Emerg Med. 2021;41:96–103.
  • Elias P, Poterucha TJ, Jain SS, et al. The prognostic value of electrocardiogram at presentation to emergency department in patients with COVID-19. Mayo Clin. Proc. 2020;95(10):2099–2109.
  • Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of COVID-19 in New York City. N Engl J Med. 2020;382(24):2372–2374.
  • Gottlieb M, Sansom S, Frankenberger C, et al. Clinical course and factors associated with hospitalization and critical illness among COVID-19 patients in Chicago, Illinois. Acad Emerg Med. 2020;27(10):963–973.
  • Chen L, Feng Y, Tang J, et al. Surface electrocardiographic characteristics in coronavirus disease 2019: repolarization abnormalities associated with cardiac involvement. ESC Heart Fail. 2020;7(6):4408–4415.
  • Li Y, Liu T, Tse G, et al. Electrocardiograhic characteristics in patients with coronavirus infection: a single‐center observational study. Ann Noninvasive Electrocardiol. 2020;25:e12805.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.